These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22628)

  • 1. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
    Soroko FE; Mehta NB; Maxwell RA; Ferris RM; Schroeder DH
    J Pharm Pharmacol; 1977 Dec; 29(12):767-70. PubMed ID: 22628
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
    Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
    Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
    [No Abstract]   [Full Text] [Related]  

  • 4. Quipazine, a new type of antidepressant agent.
    Rodríguez R; Pardo EG
    Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal models used in prediction of antidepressant effects in man.
    Cooper BR; Howard JL; Soroko FE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
    Boksay IJ; Popendiker K; Weber RO; Söder A
    Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects.
    Peck AW; Bye CE; Clubley M; Henson T; Riddington C
    Br J Clin Pharmacol; 1979 May; 7(5):469-78. PubMed ID: 475943
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of Su-19789B, a unique central nervous system stimulant.
    Chernov HI; Wilson DE; Partyka DA; Bernard PS; Huebner CF
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):34-44. PubMed ID: 4393633
    [No Abstract]   [Full Text] [Related]  

  • 10. Bupropion, d-amphetamine, and amitriptyline-induced conditioned taste aversion in rats: dose effects.
    Miller DB; Miller LL
    Pharmacol Biochem Behav; 1983 May; 18(5):737-40. PubMed ID: 6407035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of 9-gamma-methylaminopropyl-9,10-dihydro-9,10-methanoanthracene-HCl (ID-9206-HCl), a new potent antidepressant.
    Fukushima H; Nakamura M; Yamamoto H
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):163-76. PubMed ID: 931463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii.
    Dubey MP; Srimal RC; Nityanand S; Dhawan BN
    J Ethnopharmacol; 1981 Jan; 3(1):1-13. PubMed ID: 7193263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclohexylphenoxy amidoximes and imidazolines with antidepressive and alpha-adrenergic activity.
    Picciòla G; Carissimi M; Ravenna F; Gentili P; Carenini G
    Arzneimittelforschung; 1979; 29(5):729-38. PubMed ID: 40574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and toxicological studies of binodaline hydrochloride.
    Jahn U; Adrian RW; Ismail S; Michos N
    Arzneimittelforschung; 1983; 33(5):726-39. PubMed ID: 6683551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion hydrochloride.
    Dufresne RL; Weber SS; Becker RE
    Drug Intell Clin Pharm; 1984 Dec; 18(12):957-64. PubMed ID: 6439541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacological effects of doxepin hydrochloride].
    Ueki S; Ogawa N; Watanabe S; Gomita Y; Araki Y
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):716-61. PubMed ID: 4676614
    [No Abstract]   [Full Text] [Related]  

  • 18. [General pharmacological effects of a psychotropic agent, doxepin hydrochloride].
    Otsuki I; Ishikawa J; Sakai M; Shimabara K; Momiyama T
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):762-99. PubMed ID: 4676615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
    Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
    Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.